Development of in House ELISAs to Detect Antibodies to SARS-CoV-2 in Infected and Vaccinated Humans by Using Recombinant S, S1 and RBD Proteins. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/diagnostics12123085
PubMed Identifier: 36553092
Publication URI: http://europepmc.org/abstract/MED/36553092
Type: Journal Article/Review
Volume: 12
Parent Publication: Diagnostics (Basel, Switzerland)
Issue: 12
ISSN: 2075-4418